Major surgery is associated with a postoperative hypercoagulable state related to the surgical trauma that may lead to thromboembolic complications. To the investigators knowledge, only two series have reported the risk of PE after liver surgery with an incidence of up to 6.3% The purpose of this study is to identify the independent risk factors associated with the development of PE after elective liver surgery.

All patients that underwent elective liver resection for both malignant and benign diseases.

Procedure: Liver resection

Hepatectomy including both minor and major.

Other Name: Hepatectomy, liver resection

Radiation: Computed Tomography

Computed Tomography +/- pulmonary angiography

Other Name: CT, CTPA, CT-PA, MSCT, MSCT-PA

Eligibility

Ages Eligible for Study:

18 Years and older

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Sampling Method:

Non-Probability Sample

Study Population

All consecutive patients that will undergo liver resection for any type of liver disease.

Criteria

Inclusion Criteria:

Age >18 years

Malignant liver diseases

Benign liver diseases

Exclusion Criteria:

Age <18 years

Previous history of thromboembolic events

Living Donor hepatectomies

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01486511